BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37367632)

  • 1. Stratifying Risk of Future Growth Among Sporadic Vestibular Schwannomas.
    Marinelli JP; Schnurman Z; Killeen DE; Nassiri AM; Hunter JB; Lees KA; Lohse CM; Roland JT; Golfinos JG; Kondziolka D; Link MJ; Carlson ML
    Otol Neurotol; 2023 Aug; 44(7):e519-e524. PubMed ID: 37367632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous Volumetric Tumor Regression During Wait-and-Scan Management of 952 Sporadic Vestibular Schwannomas.
    Marinelli JP; Killeen DE; Schnurman Z; Nassiri AM; Hunter JB; Lees KA; Lohse CM; Roland TJ; Golfinos JG; Kondziolka D; Link MJ; Carlson ML
    Otol Neurotol; 2022 Oct; 43(9):e1034-e1038. PubMed ID: 36001695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term natural history and patterns of sporadic vestibular schwannoma growth: A multi-institutional volumetric analysis of 952 patients.
    Marinelli JP; Schnurman Z; Killeen DE; Nassiri AM; Hunter JB; Lees KA; Lohse CM; Roland JT; Golfinos JG; Kondziolka D; Link MJ; Carlson ML
    Neuro Oncol; 2022 Aug; 24(8):1298-1306. PubMed ID: 34964894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural History of Growing Sporadic Vestibular Schwannomas: An Argument for Continued Observation Despite Documented Growth in Select Cases.
    Marinelli JP; Lees KA; Lohse CM; Driscoll CLW; Neff BA; Link MJ; Van Gompel JJ; Carlson ML
    Otol Neurotol; 2020 Oct; 41(9):e1149-e1153. PubMed ID: 32925859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural History of Sporadic Vestibular Schwannoma: A Volumetric Study of Tumor Growth.
    Lees KA; Tombers NM; Link MJ; Driscoll CL; Neff BA; Van Gompel JJ; Lane JI; Lohse CM; Carlson ML
    Otolaryngol Head Neck Surg; 2018 Sep; 159(3):535-542. PubMed ID: 29685084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural History of Growing Sporadic Vestibular Schwannomas During Observation: An International Multi-Institutional Study.
    Marinelli JP; Carlson ML; Hunter JB; Nassiri AM; Haynes DS; Link MJ; Lohse CM; Reznitsky M; Stangerup SE; Caye-Thomasen P
    Otol Neurotol; 2021 Sep; 42(8):e1118-e1124. PubMed ID: 34121081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Metformin With Volumetric Tumor Growth of Sporadic Vestibular Schwannomas.
    Armstrong MF; Lohse CM; Lees KA; Carlson ML
    Otol Neurotol; 2021 Aug; 42(7):1081-1085. PubMed ID: 34260511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed Tumor Growth in Vestibular Schwannoma: An Argument for Lifelong Surveillance.
    Macielak RJ; Patel NS; Lees KA; Lohse CM; Marinelli JP; Link MJ; Carlson ML
    Otol Neurotol; 2019 Oct; 40(9):1224-1229. PubMed ID: 31469794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Imaging in the Diagnosis and Management of Patients With Vestibular Schwannomas.
    Dunn IF; Bi WL; Mukundan S; Delman BN; Parish J; Atkins T; Asher AL; Olson JJ
    Neurosurgery; 2018 Feb; 82(2):E32-E34. PubMed ID: 29309686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gamma Knife radiosurgery for treatment of growing vestibular schwannomas in patients with neurofibromatosis Type 2: a matched cohort study with sporadic vestibular schwannomas.
    Kruyt IJ; Verheul JB; Hanssens PEJ; Kunst HPM
    J Neurosurg; 2018 Jan; 128(1):49-59. PubMed ID: 28128697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying at diagnosis the vestibular schwannomas at low risk of growth in a long-term retrospective cohort.
    Wolbers JG; Dallenga AH; van Linge A; Te West M; Kummer EE; Méndez Romero A; Pauw BK; Wieringa MH
    Clin Otolaryngol; 2016 Dec; 41(6):788-792. PubMed ID: 27086938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wait-and-scan management in sporadic Koos grade 4 vestibular schwannomas: A longitudinal volumetric study.
    Schouten SM; Cornelissen S; Langenhuizen PPHJ; Jansen TTG; Mulder JJS; Derks J; Verheul JB; Kunst HPM
    Neurooncol Adv; 2024; 6(1):vdad144. PubMed ID: 38187870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing Linear and Volumetric Tumor Measurements During Observation of Growing Sporadic Vestibular Schwannomas.
    Killeen DE; Marinelli JP; Lohse CM; Lees KA; Link MJ; Carlson ML; Hunter JB
    Otolaryngol Head Neck Surg; 2023 Sep; 169(3):633-641. PubMed ID: 36758946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimensional segmented volumetric analysis of sporadic vestibular schwannomas: comparison of segmented and linear measurements.
    Walz PC; Bush ML; Robinett Z; Kirsch CF; Welling DB
    Otolaryngol Head Neck Surg; 2012 Oct; 147(4):737-43. PubMed ID: 22588731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rate of Initial Hearing Loss During Early Observation Predicts Time to Non-Serviceable Hearing in Patients With Conservatively Managed Sporadic Vestibular Schwannoma.
    Carlson ML; Dowling EM; Lohse CM; O'Connell BP; Driscoll CLW; Haynes DS; Link MJ; Hunter JB
    Otol Neurotol; 2019 Dec; 40(10):e1012-e1017. PubMed ID: 31634279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vestibular schwannoma: role of conservative management.
    Suryanarayanan R; Ramsden RT; Saeed SR; Aggarwal R; King AT; Rutherford SA; Evans DG; Gillespie JE
    J Laryngol Otol; 2010 Mar; 124(3):251-7. PubMed ID: 20003606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-associated macrophages are related to volumetric growth of vestibular schwannomas.
    de Vries M; Briaire-de Bruijn I; Malessy MJ; de Bruïne SF; van der Mey AG; Hogendoorn PC
    Otol Neurotol; 2013 Feb; 34(2):347-52. PubMed ID: 23295727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Volumetrical measurements in vestibular schwannoma, the influence of slice thickness and patient's repositioning.
    Luppino FS; Grooters E; de Bruïne FT; Zwinderman AH; van der Mey AG
    Otol Neurotol; 2006 Oct; 27(7):962-8. PubMed ID: 17006347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of growth factor receptor expression with clinical growth in vestibular schwannomas.
    O'Reilly BF; Kishore A; Crowther JA; Smith C
    Otol Neurotol; 2004 Sep; 25(5):791-6. PubMed ID: 15354013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conservative management of vestibular schwannoma: expectations based on the length of the observation period.
    Fayad JN; Semaan MT; Lin J; Berliner KI; Brackmann DE
    Otol Neurotol; 2014 Aug; 35(7):1258-65. PubMed ID: 24914786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.